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'~"~ Serum Protein A: Detection In Human An)yield 
Atherosclerotl¢ Lesions and Association With Acute 
Coronary  Syndromes 
J, Krouxor, K, Buohor, P, Salbach, L, John, W, KOblor, Inn~m Medlzln ill, 
UnlwmlttH Hpldelt~rg, Heidelberg, Germany 
The anl, ltO phase protein serum omylotd A (SAA) hoe boon shown to be 
elevated (n oautn myocardial Infllrctlon nnd unstable angina, The_ patients 
with )meltable ~ngln~ who had tits htghoat SAA levels, had tl significantly 
Itlgher rl~k for the development nt myooardlol Infarction, Mum recently saute 
phase proteins hnvo ~lso been Impltontad In the progress el athoroBotorosls, 
It thus was of interest to st,dy dopo~ltlon of SAA In ~therosclorotlo Iostona, 
Specimen from 41 concoo,tlv8 coronan/(lthoraotomlos (22 p~tlonts with 
unstable, Ig with stable angina) ware InvoMIgatod lot the presence of SAA 
hy Immuncoytochomlsth/, U~Ing anllbodloa dlro~tod ngalns( SAA, a.netin, 
van Wlllobmnd factor and Moo.1 Bomlqtt¢~ntttntlon n d localization of SAA 
Immunoraactlvlht was podormed, 
90 of the specimen could he an~lytad, The nmotmt o! SAA immt~noro. 
activity was graded O, 1 or ~ by two Independent blinded invcotigatora, ~AA 
~coms wore then cormlP, tod to pr~ttftnta olinlt~nl wmptom~, Patients with st,~. 
bla ~ngln~ hod ~ SAA.pl~q~lo scare of O,B t 030 88 opposed to t ,1 :t~ 0,71 
tar p~tlenta wlth unstable angina (p - O,05l, ImmunoroncINlty eoioc~lited 
pro_domino)ely to smooth muscle coils, however, was also found in close 
proximity to monocyto~ and endothelial coils. 
It has boon demonstrated In vitro that SAA can land to monocyto migration 
and ~cttva(ion, Thus It l~ hypotho~ltod tidal SAA localized in the artotioscle. 
retie lesion Ioad~ to destabllttatlon and cub.sequent rupture of tire plaque as 
well ,=is progress el the athorosclsrotlo lesion, 
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~ Elevated Serum Homocyatelne: Reversible Risk 
Factor In Patients With Coronary  Vaaoapaam 
K..H, Ryu, S..W, Hen, D,..I, Oh, Y, Lea, Hallym Univ. Hospital, Seoul, Korea 
Homocyatnlna (Hey) Is n metnboltte of mothtentno with 8tlherogonic proper- 
ties via endothelial dysfunction, We nxnmmod the relationships between the 
risk of patients with coronan/vasospasm and serum total Hey, loin)o, vitamin 
912 and plasma vitamin 912 
Methods: Fasting serum Hey, In)ate and vitamin B12 and plasma vita- 
mtn 96 Concentrations worn determined in 20 patients (8 men, 12 women, 
age 52,7 ~ t2,2) with coronnn/vasospasm, which wore demonstrated by 
coronan/anglographleally focal vasospasm with angina, were compared with 
healthy age and sex-matched controi (8 men and 7 women, age 5t .9 ~, 12,5). 
Rosutts: Moan serum Hcy concentration was higher in case group than 
centre1 (15,0 ~ 1 1 vs 10,9 i 1,3 ~mol/L, p = 0.02). Serum rotate (6.5 t 
0,9 vs, 96  t 0,9 ng/L, p = 0,02), vitamin Bt2 (534,4 ~ 59.6 vs, 836.8 :~ 
84,2 petroL, p = 0 007) and plasma vitamin B6 (75,7 ~ tO.9 vs, 128,9 ~ 13.0 
molfL, p =, 0,033) were significantly lower In case group than control, 
Conclt~s~on: Those data suppofl the hypothesis that elevated serum Hcy 
is n risk factor' (n patients with coronary vasospnsm and low totals, vitamin 
912 and vitamin 96 may account for elevated homocystoin level Since 
homocysteine can be reduced by adminlstraion of relate and vitamin St2, a 
possible therapeutic role to~ those agents may exist in patients with coronary 
vasospasm 
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~ CRUISE: Can Rout ine In t ravascu lar  U l t rasound 
In f luence  Stoat Expansion? Analysis of  Outcomes  
PJ. Fitzgerald, M. Hayase, G.S, Mintz, R, Kuntz, J.W. Moses, D.J. Diver, 
E. Doutsch, C.A. Simonton, D.S. Bairn, M.B. Loon, P.G. Yock. For the 
CRUISE Investigators; Sanford University Medical Center CA, USA 
CRUISE, the IVUS substudy of the STAPS trial, was designed to ~ ~easuro the 
impact of IVUS guidance on stent deployment in the high-pressure era. Ten 
centers were pmspoctivety assigned to stent deployment using ultrasound 
guidance (UG) and 7 to angiographic guidance alone (AG) with blinded IVUS 
at the end of the procedure, A total of 538 cases were enrolled with completed 
quantitative coronary angiography (QCA), ultrasound analysis (QCU), and 
clinical event rates in 499 patients. Outcome as assessed by target vessel 
rovasculadzation (TVR) was defined as clinically driven repeat PTCA or 
CABG of the index vessel. 
Results: Following stont optlmlzntion: 
OCA UG (n - 270) AG (n ~ 229) p-value 
RoL Lumen :3 t3 t 0,46 3 03 ! 0 50 0 02 
MLD Btnnt 2.52 .t 0.48 2,40 t 0,54 0009 
%Dl(t sleno~l~ t0,2 ~l 12,5 20,7 ~; 12,7 NS 
QCU 
Rot, Lumen 992 t ~,04 9,62 t 3 t~ NS 
Rot. Vessel 17B~ t 4.55 I('L6T t 480 N5 
Mln. Brant D~. ~.8~ ~ 0.55 ~50 t 8 43 0038 
Mtn, Stent Ares }',76 t 132 7 tt I k t3 e 001 
l"~tR 24~70 (S 9%t 34~0 (t4.B%) 004 
Conclusion; Those d~ttn Irom the CRUISE (rial st)egos) that ultrasound 
guidanoo roB)Ills in ~ larger stun( Igrson oma compared to angiogmph~ 
gttidanoe alone, resulting in n 39% m!etWe reduction in tablet vessel rovas- 
oulad;tntion, 
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~ Se l f -expandable  S lent  Versus  Balloon-expandable 
Stent; A Serial VolumMrlo Analysis by Intravascular 
Ultrasound 
Y, Kohayaslli, P S, Teirstoln, S.R L~!atley, C.L Brown, Ill, L.G. Christie. 
R,V, Mafthews, B,S, Schwartz, A.C. Do France, C.E. Haeden, P.G. Yock, 
P J  Fitzgerald. Stnnton~ Universt~ SlantoK( CA, USA 
To evaluate naointimal proliferation and chronic sleet roost in a sell-expand- 
able 8tent (SE, RADIUS") and a ballnon~oxpandabto stoat (BE. Palmaz. 
Schatz"), 91 patients from five centers wore entered into the intravascular ul- 
trasound (IVUS) substudy of the SCORES (Sleet COmparative REStenos=s) 
trial IVUS scans were p~ffomled in each patient foltowmg stere dep l~ 
and at 6.month follow-up (ftu). To date, sonal volume)ire data are available 
for the first 20 patients (SE; 8, BE: 12) completing flu (184 ± 27 days). 
R~ults: SE stents increased 20.2% in cross sectmnal area and everett 
vohtmo (121.9 ~ 36.3 mm ~ to 146.,5 t 47.P mm ~, p < 0.01). However. m 
BE stunts, no significant change in overall area or volume was observed 
(144.2 ~: 62.8 mm 3 to 136.4 ~: 52.2 mm 3, p = ns). In addition, no s)geit,,cant 
diftorenc~ in neelnttmal volume index (neath)final volume/stent vohm~e at l/u) 
was observed between the two groups (329 ± 24.0% in SE, 21.6 =: 16.0% in 
BE, p = ns). In each group, the minimum lumen area decreased s)gndmantly 
over t~me, however, SE stents trended (not stattst¢alty significant) to have 
loss late lumen toss (6.70 ~- 1.19 mm; to 4.94 t 2.57 mm ~, late lumen loss: 
1 76 ~: 2.29 mm ~) compared to BE stents (7.28 t 2.24 mm 2 to 4.32 ~. 1 52 
ram", late It=men loss: 2.9} t 257 mm'~). 
Conclusions: These preliminary results suggest that SE stents increase 
m overall size within 6-month flu period, have inttmal proliferation similar to 
that of BE stunts and trend towards smaller late lumen loss 
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~--1  Restenosls Al ter  Coronary  Stent ing by  Gu ided  
In t recoronary  Dopp ler  F low Veloci ty  Reserve 
Measurements 
M. Haude, O. Baumged, G Caspari, D. Welge. J. Go, F Liu, R. Eft)el. 
Cardaotogy Oepartment. University Essen. Germany 
Background.- Coronary flow velocity ratio [CVR) assessed by intraceronary 
Doppler guide wires (Cardiometncs, Mountain View, USA) atlows to estimate 
the functional result of a coronary intervention. 
Methods: Instead of using a general cut-off value tar CVR (~-2.5 in the 
DEBATE I teal) we guided the stent procedure by the individual measure- 
ment el CVR in a non-stenotic reference aden/. To evaluate the impact of 
this strategy on the occurrence ot restenosis (--50% diameter stenosis), we 
measured CVR distal to the target lesion (CVRd) and in a reference vessel 
(CVRref) in 50 patients (pts) with LAD stenoses. Measurements were re- 
peated after PTCA, after stenting, and after 6 months. CVR was calculated 
as the ratio of hyperemic (18 ~=g adenosine ic) and baseline flow velocity Ad- 
ditionally quantitative coronary angiography (minimal lumen diameter, MLD) 
of the target lesion was performed. 
Botore After After After Restenosis 
PTCA PTCA stent 6 months rate 
CVPI 1 2 ~ e 5 2.5 • 0 7" 3.1 ~- 06 § 2.9 ± 0.8 
CVRd .CVRmf 0/50 18/50 45/50 46/50 4/45 (0%) 
CVRd >2.5 0/50 22/50 40/50 40/50 8/40 (20%) 
MLD [mm] 0.9 :~ 0.5 2.1 ± 0.7 3.0 ~. 0.5 2.1 ± 0.8 
Residual stenosis 0/50 18/50 50/50 32/50 
• 35% 
• : p . 0.01 versus b~lore PTCA; §: p - 0.01 versus after PTCA 
